Healthcare Regulatory Affairs Outsourcing Market Size, Share, Growth Report 2032

Healthcare Regulatory Affairs Outsourcing Market Insights

Zion Market Research has published a report on the global Healthcare Regulatory Affairs Outsourcing Market, estimating its value at USD 7.55 Billion in 2023, with projections indicating that it will reach USD 18.86 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 10.7% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Healthcare Regulatory Affairs Outsourcing Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Healthcare Regulatory Affairs Outsourcing Market: Overview

Emerging biotech & pharmacy markets across globe has resulted into necessity for healthcare regulatory affairs outsourcing activities. Moreover, pharmacy firms are working with contract research organizations for new drug development. Surge in incidences of chronic disorders will generate new growth avenues for healthcare regulatory affairs outsourcing industry in coming years. Apparently, period of drug approval is very expensive and time-consuming and requires tedious process of documentation. However, to prevent these issues firms are entering into alliances with firms in business of healthcare regulatory affairs outsourcing for quick documentation & drug approval. This has translated into humungous demand for healthcare regulatory affairs outsourcing activities.

Request Free Sample

Healthcare Regulatory Affairs Outsourcing Market: Growth Drivers

Constant surge in compliance measures, strict legislations governing drug development & approvals, and high proportion of medicine withdrawals has compelled biotech, pharm, and life science firms to outsource healthcare regulatory affairs activities with a view to reduce operating costs. This, in turn, will enlarge scope of growth of healthcare regulatory affairs outsourcing industry over forecasting period. In addition to this, regulatory support is necessary for large number of processes in clinical studies including manufacturing & controls methods, healthcare report writing, data management processes, regulatory chemistry procedures, and labeling & liaison methods. This will proliferate size of healthcare regulatory affairs outsourcing industry over assessment period. Moreover, outsourcing of non-core activities will help firms concentrate on various research & development activities.

In addition to this, outsourcing of healthcare regulatory affairs is predicted to assist firms in focusing on core competencies, minimizing service delivery period, and enhance competitive edge for firms. This will create new growth avenues for healthcare regulatory affairs outsourcing market over forecasting timespan. Nevertheless, huge risks related to data security issues in firms can pose a threat to expansion of healthcare regulatory affairs outsourcing industry in foreseeable future.

Healthcare Regulatory Affairs Outsourcing Market: Report Scope

Healthcare Regulatory Affairs Outsourcing Market: Regional Landscape

North America To Account Majorly Towards Overall Market Size By 2032

Growth of healthcare regulatory affairs outsourcing market in North America over assessment period can be due to surge in number of copyright expiries and focus on new product launches in countries such as the U.S. and Canada. Apart from this, need for quick drug approvals to gain competitive advantage over business rivals and acquire major industry share has resulted in healthcare firms outsource healthcare regulatory affairs activities in countries such as the U.S. This has translated into humungous growth of regional market.

Competitive Landscape

Key players profiled in study and influencing market growth are:

• Accell Clinical Research, LLC
• Medpace, Inc.
• Wuxi AppTec
• Promedica International
• PARAXEL International Corporation
• PRA Health Sciences, Inc.
• Labcorp Drug Development
• Freyr Solutions
• Criterium, Inc.
• Quintiles IMS Holdings, Inc.

The global Healthcare Regulatory Affairs Outsourcing Market is segmented as follows:

By Services

• Regulatory Writing &  Publishing
• Regulatory Submissions
• Clinical Trial Applications & Services Registrations
• Regulatory Consulting & Legal Representation

By End-User

• Mid-Size Pharmaceutical Companies
• Large Pharmaceutical Companies  
• Biotechnology Companies
• Medical Device Companies
• Food & Beverage Companies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa